AllianzIM U.S. Large Cap Buffer10 Jan ETF (NYSEARCA:AZAJ – Get Free Report)’s stock price rose 1.6% during mid-day trading on Friday . The company traded as high as $35.26 and last traded at $ ...

Exclusively licensed from Queen’s University Belfast (QUB), this composition of matter patent, one of the most robust forms of intellectual property protection, grants Niagen Bioscience ...

Allianz Global Assistance is one of the largest travel insurance companies and offers proven trip protection for vacations across the world. Allianz travel insurance helps cover the cost of delays ...

FORMER Tyrone forward Pascal Canavan has paid tribute to the advocacy displayed by key figures in Dublin GAA around the plight of the Palestinian people.

Allianz SE is stepping up efforts to forge an alliance with Mukesh Ambani-led Jio Financial Services (JFSL) for a second stab at the domestic life and general insurance market, said people in the know ...

FRANKFURT, March 19 (Reuters) - A consortium that includes Allianz (ALVG.DE), opens new tab, BlackRock and T&D Holdings are investing in Viridium Group in a 3.5 billion euro ($3.82 billion ...

Fresh off a pivot from commercial pharma business to preclinical biotech, Aadi Bioscience has rebranded to better match its strategic reboot. The company will henceforth be known as Whitehawk ...

“The execution of the SPAs marks the culmination of constructive and amicable discussions to ensure a seamless transfer of the stake of Allianz,” Bajaj Finserv said. (Photo source ...

Bajaj Finserv is buying Allianz SE's 26% stake in life and general insurance ventures for ₹24,180 cr, ending their 24-year partnership. Bajaj will have full ownership of both insurance companies.

German insurance giant Allianz SE has decided to exit from its Indian insurance joint ventures with the Bajaj group. Nearly one and a half months after the government allowed 100 per cent FDI in ...

Company reports financial results for the fourth quarter and full-year 2024, and will host a conference call tomorrow, March 19 at 8:30 am ET The three assets in the portfolio are in-licensed from ...

A Boston biotech try­ing to bring trans­fer RNA (tR­NA) bi­ol­o­gy to the drug de­vel­op­ment field has shut­tered op­er­a­tions, End­points News has learned.